Company record
Remel, Inc
0 FDA warning letters since 2023 and 5 recalls in the last 12 months.
Get an email the day FDA posts anything new about Remel, Inc.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Nov 11 | Class II | Remel, Inc Device |
Yeastone Broth, 11ML, 10/BOX, used in antibiotic susceptibility testing of mycological clinical specimens Affected lot did not meet specifications. Product may report false susceptibility to antifungal agents, specifically within the Azole family. |
| Jul 8 | Class II | Remel, Inc Device |
GC Agar Base (150mm) 10/PK R04030; GC Agar Base (100mm) 10/PK R01460 Reduced or no recovery of some strains of Neisseria gonorrhoeae. |
| Apr 22 | Class II | Remel, Inc Device |
Yeastone Broth, 11ML, 10/BOX YY3462 Products may report incorrect AST results during quality control. Health consequences may include delayed response or the need to change to another antifungal agent if laboratory ignores Quality Control test result. |
| Mar 4 | Class II | Remel, Inc Device |
Campy CVA Medium 100/PK, R01272 Customer complaints report low to no recovery of Campylobacter Jejuni ATCC 33291 on identified lot of medium. |
| Dec 3, 2025 | Class II | Remel, Inc Device |
1. CAMHB W/LHB, MANUAL, 11ML, 10/BOX YCP112-10 2. BRUCELLA BROTH, 11ML, 10/BOX YT3450 Products may contain contamination, which may result in a darker or brown media color. |